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The myogenic response is an inherent property of resistance arteries that warrants
a relatively constant blood flow in response to changes in perfusion pressure
and protect delicate organs from vascular insufficiencies and excessive blood flow.
This fundamental phenomenon has been extensively studied aiming to elucidate
the underlying mechanisms triggering smooth muscle contraction in response to
intraluminal pressure elevation, particularly, Rho-associated kinase (ROK)-mediated
Ca2+-independent mechanisms. The size of the resistance arteries limits the capacity
to examine changes in protein phosphorylation/expression levels associated with ROK
signaling. A highly sensitive biochemical detection approach was beneficial in examining
the role of ROK in different force generation mechanisms along the course of myogenic
constriction. In this mini review, we summarize recent results showing direct evidence
for the contribution of ROK in development of myogenic response at the level of
mechanotransduction, myosin light chain phosphatase inhibition and dynamic actin
cytoskeleton reorganization. We will also present evidence that alterations in ROK
signaling could underlie the progressive loss in myogenic response in a rat model of
type 2 diabetes.
Keywords: rho-associated kinase, myogenic response, calcium sensitization, actin polymerization, integrins,
type 2 diabetes
THE MYOGENIC RESPONSE
Over 100 years ago, Bayliss (1902) elegantly demonstrated a unique property of arterioles whereby
these vessels constricted in response to an increase in perfusion pressure and dilated when the
internal pressure was reduced. In his study, the arterial reaction was found to be “myogenic” in
nature, inherent to the vascular smooth muscle coat of the arteries, and not dependent on neuronal
supply. Later studies showed that this phenomenon existed in a variety of vessel types including
mesenteric, skeletal muscle, renal, and cerebral arterioles (Cole and Welsh, 2011; Davis, 2012; Abd-
Elrahman et al., 2015b).
Pressure-induced tone is crucial for various aspects of the cardiovascular homeostasis. The sum
of effects of endothelial activation by blood flow, sympathetic neuronal control, and humoral
factors modulates the myogenic response and sets the peripheral vascular resistance and thus
contributes to blood pressure regulation. Moreover, the arteriolar myogenic response tightly
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regulates the capillary hydrostatic pressure against fluctuations
in systemic pressures thus, stabilizing capillary flow and
shielding downstream structures from the damaging effects of
high intravascular pressure (Davis, 2012). Thus, an abnormal
myogenic response could have major consequences for various
organ functions and may form the basis of vascular pathologies.
Advances in the study of myogenic tone over the last two
decades unfolded the crucial role of Rho-associated kinase (ROK)
in the myogenic response of resistance arteries. In this mini
review, we will focus on the role of ROK in myogenic constriction
in health and disease condition, specifically type 2 diabetes. We
will provide a summary of our findings pertaining to the direct
detection of ROK phosphorylated protein targets in the context
of myogenic constriction using a highly sensitive western blotting
detection technique.
THE MOLECULAR MECHANISM OF THE
MYOGENIC RESPONSE
The cascade of events between the initial pressure rise and
the increased force generation was subject to extensive study.
Numerous studies utilized various experimental techniques
to offer models and explanations of the molecular processes
involved in pressure sensation and signal transduction to force-
production mechanisms involving cross-bridge cycling and
cytoskeletal reorganization. A widely accepted model of smooth
muscle contraction involves an increase in the cytosolic calcium
levels, which, via the stimulation of calcium and calmodulin-
dependent kinase, activates myosin light chain kinase (MLCK)
with the subsequent phosphorylation of the 20 kD regulatory
light chain of myosin (LC20) leading to increased actin/myosin
interaction followed by cross-bridge cycling and cell shortening
(Davis and Hill, 1999; Hill et al., 2001; Figure 1).
Pressure Sensing,
Mechanotransduction, and Membrane
Depolarization
In 1998, Knot and Nelson published an elegant study showing
a strong correlation between intraluminal pressure increase,
membrane depolarization, increased intracellular calcium, and
vessel constriction in isolated pressurized rat cerebral arteries
(Knot and Nelson, 1998). Thus, the traditional view of the
initiation of myogenic contractility holds that the pressure-
dependent membrane depolarization is followed by the activation
of voltage-dependent calcium channels and calcium influx
leading to an elevation of intracellular calcium. This pressure-
dependent membrane depolarization is triggered by a pressure-
sensing element existing in or interacting extensively with the
smooth muscle cell membrane, that is activated by changes in
intravascular pressure (Davis, 2012).
Several membrane proteins were proposed as candidates
for the function of the pressure sensor; among which are
integrins, stretch-activated ion channels, and G protein-
coupled receptors (GPCRs). Integrins are heterodimeric
transmembrane proteins that form a unique link between the
smooth muscle cytoskeleton and extracellular matrix that is
suitable for bi-directional signal transfer (Hill and Meininger,
2012). One accepted model for the initiation of myogenic
constriction is that the increased wall tension exerted by
intraluminal pressure leads to structural deformities in the
extracellular matrix proteins exposing integrin-interacting
motifs that initiate downstream signaling required for
development of myogenic constriction (Hill and Meininger,
2012).
On the other hand, the assumption that a stretch-activated
cation channels, such as transient receptor potential (TRP)
channels and the epithelial sodium channels, act as a
mechanosensor becomes reasonable given the fact that an
early event in the cascade culminating in the arterial myogenic
contractility in response to increased intraluminal pressure is
smooth muscle membrane depolarization (Kizer et al., 1997;
Jernigan and Drummond, 2005; Sharif-Naeini et al., 2008;
Carlson and Beard, 2011; Kim et al., 2012). Yet, recent reports
support a direct role for GPCRs as mechanosensors independent
of activation by their respective ligands. Angiotensin receptor of
the AT1 sub-type was shown to switch to an active conformation
in response to cell stretch in a ligand-independent manner
(Yasuda et al., 2008). The same receptor was shown later to
contribute to the myogenic response of mesenteric, skeletal,
and renal arterioles via coupling to Gq/11 signaling cascades
(Schleifenbaum et al., 2014; Hong et al., 2016). Additionally,
activation of one TRP channel (TRPM4) and its contribution
to membrane depolarization and myogenic constriction was
shown to be dependent on mechanical activation of G-protein
coupled purinergic receptors with subsequent increase in ROK
activity in response to pressure (Li et al., 2014; Li and Brayden,
2017). Another study demonstrated a clear involvement of
the P2Y purinergic receptor in the development of mesenteric
myogenic tone with implicated signaling to RhoA (Kauffenstein
et al., 2016). Interestingly, activation of sphingosine-1-phosphate
(S1P) receptors in response to pressure-induced S1P generation
could be another mechanism by which a GPCR contribute to
mechanotransduction (Kroetsch and Bolz, 2013; Sauve et al.,
2016). This pathway was linked early on to the activation of
RhoA/ROK signaling (Bolz et al., 2003). Other GPCR types
were implicated but further validation is needed to support this
mechanotransduction mechanism.
Calcium-Independent Mechanisms
Several lines of evidence suggested that calcium-mediated
MLCK activation and LC20 phosphorylation cannot be the only
mechanism underlying force generation during the myogenic
response. Studies employing ratiometric calcium dyes (Fura-2)
to determine changes in the concentration of intracellular
calcium in the pressure range eliciting the myogenic response
demonstrated little to no change in calcium levels with increasing
pressure. In 1997, D’Angelo and colleagues showed that despite
the differences in the magnitude of myogenic constriction
produced by different intravascular pressure levels, there were
no differences detected in the steady state intracellular calcium
concentration (D’Angelo et al., 1997). In 2002, Osol and
colleagues demonstrated similar results whereby membrane
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FIGURE 1 | Detailed contemporary model for the molecular basis of the myogenic response. Intravascular pressure between 20 and 40 mmHg evokes
depolarization via non-selective cation channels (NSCC), increases voltage-dependent Ca2+ channels (VDCC) activity, a rise in cytosolic Ca2+ concentration ([Ca2+]i)
and vasoconstriction due to activation of myosin light chain kinase (MLCK) and phosphorylation of myosin. The resulting activation of MLCK and inhibition of myosin
light chain phosphatase (MLCP) afforded by basal Rho-associated kinase (ROK) activity lead to increased pMyosin content. The release of Ca2+ from SR in the form
of waves also contributes to the global rise of ([Ca2+]i. Intravascular pressures between 40 and 80 mmHg stimulate integrins leading to focal adhesion kinase (FAK)
activation by autophosphorylation at Y397. FAK autophosphorylation permits Src family kinase (SFK) binding and its subsequent autophosphorylation at Y416 and
activation. SFK in turn phosphorylates FAK to further enhance its catalytic activity, leading to activation of Rho guanine nucleotide exchange factors (RhoGEFs) to
exchange GTP for GDP of RhoA. RhoA-GTP is the active form of RhoA that activates ROK to phosphorylate MYPT1-T855 and suppress MLCP activity. Further
elevation of pressure (>80 mmHg) triggers actin polymerization downstream of FAK and SFK activation. ROK contributes to the control of actin dynamics via
suppression of cofilin (COF)-mediated severing of actin filaments by LIM kinase (LIMK)-mediated phosphorylation of cofilin. Supporting literature is cited on the figure.
depolarization and intracellular calcium concentration did not
change with increased force generation in the pressure range
associated with myogenic constriction (60–140 mm Hg) (Osol
et al., 2002). These and many other observations (VanBavel et al.,
2001; Lagaud et al., 2002; Bolz et al., 2003; Gokina et al., 2005)
support the involvement of calcium-independent mechanisms in
the development of myogenic contractility. Studies demonstrated
an increased sensitivity of tone production to intracellular
calcium with increased intravascular pressure making an early
case for calcium-sensitization to be among these mechanisms
(VanBavel et al., 1998; Schubert et al., 2002). In a physiological
context where resistance arterioles are continuously producing
force in the face of maintained intravascular pressure, a
contractile mechanism that does not involve massive fluctuations
of calcium would afford the advantage of conserving calcium
signaling given the ubiquitous nature of calcium-mediated
processes (Schubert et al., 2008).
The Role of ROK
As mentioned earlier, not only was ROK reported to initiate
smooth muscle depolarization during myogenic constriction
(Li and Brayden, 2017), it was also reported to exert a
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modulatory effect on depolarization by inhibiting delayed
rectifier potassium channels (Luykenaar et al., 2009). However,
ROK-mediated calcium sensitization was implicated as an
underlying mechanism in many of the studies cited above
in support of calcium-independent mechanisms. Calcium
sensitization refers to a mechanism whereby myosin light chain
phosphatase (MLCP) inhibition shifts the equilibrium toward
the accumulation of phosphorylated LC20 without an associated
increase in calcium-induced MLCK activity (Somlyo and Somlyo,
2003). ROK-dependent phosphorylation of the myosin targeting
subunit of MLCP (MYPT1) was reported to occur at two
threonine residues, T697 (rat numbering) reported to inhibit
MLCP catalytic activity, and T855 (rat numbering) reported to
inhibit both the catalytic activity and myosin binding (Muranyi
et al., 2005). Another potential pathway for calcium sensitization
involves the protein kinase C (PKC)-mediated phosphorylation
of a 17 kD protein phosphatase inhibitor (CPI17) increasing its
inhibitory effect of MLCP (Hayashi et al., 2001). So far, a pressure-
induced change in CPI17 phosphorylation was not detected in the
context of myogenic response (Johnson et al., 2009). However,
the involvement of other PKC-mediated mechanisms remains a
very likely possibility (Lagaud et al., 2002; Johnson et al., 2009;
Moreno-Domínguez et al., 2014; El-Yazbi et al., 2015; Hong et al.,
2016).
On the other hand, an additional mechanism that can be
involved in potentially calcium- and LC20 phosphorylation-
independent manner is actin cytoskeleton reorganization.
Relatively recent evidence suggested that actin cytoskeleton is not
a static structure in the context of generating and transmitting
force in smooth muscle (Gunst and Zhang, 2008). The role of
actin cytoskeleton polymerization was implicated in myogenic
constriction as early as 1998 with the observation that treatment
with cytochalasin D, an agent that disrupted actin cytoskeleton,
caused forced dilation of pressurized arteries to occur at lower
pressures (Cipolla and Osol, 1998). An early report by Cipolla
et al. (2002) provided quantitative evidence to support de
novo actin polymerization in response to pressure increases.
This was later supported by qualitative evidence showing that
F-actin content increased in response to intraluminal pressure
elevation (Flavahan et al., 2005). Both studies showed that
cytochalasin D inhibited both actin polymerization and the
myogenic response. A role for Rho A/ROK-mediated signaling
was also implicated in smooth muscle actin cytoskeletal dynamics
involved in contraction and force generation (Numaguchi et al.,
1999; Gerthoffer, 2005).
A third calcium-independent mechanism that could be
associated with smooth muscle contraction is thin filament
regulation (Morgan and Gangopadhyay, 2001). Studies of the
myogenic constriction of rat cerebral arterioles, ruled out the
contribution of this mechanism based on a lack of detection of
an increased calponin and caldesmon phosphorylation (Moreno-
Domínguez et al., 2014). These experiments were conducted
using a western blotting method of high sensitivity (∼200-
fold) that offered an exclusive approach to accurately quantify
increases in protein phosphorylation in minute tissue segments
such as those used in isobaric myography experiments (Takeya
et al., 2008). Prior to this technical advance, direct quantification
of ROK activity and assessment of its contribution to myogenic
constriction of resistance arteries was a daunting task (Schubert
et al., 2002, 2008). This biochemical approach was employed in
a series of studies to track changes in protein phosphorylation
in different mechanotransduction and force generation pathways
leading to myogenic constriction of cerebral and skeletal muscle
arterioles as outlined below, providing a molecular context for the
role of ROK in these processes in vessels from healthy and type 2
diabetic rat model.
ROK-MEDIATED CALCIUM
SENSITIZATION IN
PRESSURE-INDUCED MYOGENIC
CONTRACTILITY
A main limitation of using pharmacological inhibitors of ROK
to assess the presumed contribution of this pathway in the
myogenic tone is the lack of differentiation between whether the
observed tone reduction is due to suppression of basal (pressure-
independent) ROK-mediated sensitization vs. inhibition of a
pressure-evoked ROK activity (Schubert et al., 2008). Several
elegant experimental designs were employed to circumvent this
limitation including the assessment of the relative sensitivity
of the intracellular calcium vs. tone relationship to ROK
inhibitors at different pressure levels (Schubert et al., 2002), the
demonstration of the need for a higher concentration of the
inhibitor compound to obtain the same level of attenuation of
tone at higher pressures (Gokina et al., 2005), and increased Rho
A translocation to cell membrane and presumed ROK activation
in response to increased intravascular pressure (Dubroca et al.,
2007).
A direct link of the perceived pressure-evoked ROK activation
to a downstream effector was shown by examining the hypothesis
that increased intravascular pressure leads to a corresponding
graded increase in ROK-mediated MYPT1 phosphorylation,
MLCP inhibition, and increased LC20 phosphorylation (Johnson
et al., 2009; Moreno-Domínguez et al., 2013). These findings
are summarized in Figure 1. Using the high-sensitivity
three-step detection method, a graded increase in MYPT1
phosphorylation was evident. These findings implicated MYPT1
phosphorylation at T855 as the more likely site for regulation
of MLCP activity in the context of pressure-induced contraction
whereby myogenic constriction associated with step increases
in intraluminal pressure from 20 mmHg to 60 and 100 mmHg
was associated with an increase only in T855 phosphorylation.
A corresponding gradual increase in LC20 phosphorylation
was also observed and both increases were sensitive to
pharmacological inhibition of ROK. No change in T697
phosphorylation was recorded in the pressure range of 60–
120 mmHg and this observation was consistent in both rat
cerebral and skeletal muscle arterioles. Interestingly, vessels
segments from these vascular beds showed significant basal (low
pressure) levels of MYPT1 phosphorylation at both sites, with
only T855 phosphorylation being sensitive to ROK inhibition
(Johnson et al., 2009; El-Yazbi et al., 2010). Abolition of
basal MYPT1 T855 phosphorylation at low pressure by ROK
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inhibition prevented myogenic tone development (Johnson et al.,
2009). These results provide direct evidence for the need of
ROK-mediated sensitization in both basal and pressure-evoked
states.
Thus, the latter observation triggered a question of whether
previous data reporting the involvement of ROK-dependent
calcium sensitization via MYPT1 phosphorylation in agonist-
induced microvascular constriction pertains to basal vs. evoked
increased in ROK-mediated MYPT1 phosphorylation. Studies
using serotonin as a model vasoconstrictor agonist in the
cerebral circulation produced variable results. Sandoval et al.
(2007) concluded that serotonin treatment increased ROK-
dependent myofilament calcium sensitivity in ovine cerebral
arteries. Yet another study demonstrating the sensitivity of
the serotonin-evoked tone to ROK inhibitors was not able to
demonstrate an increase in MYPT1 phosphorylation even in the
larger rabbit basilar artery segments under control conditions
(Watanabe et al., 2005). Using the highly sensitive biochemical
detection method, serotonin evoked constriction and increased
LC20 phosphorylation at low pressure levels associated with
basal MYPT1 phosphorylation, though completely abolished by
ROK inhibition, were not associated with a further increase in
MYPT1 phosphorylation (El-Yazbi et al., 2010) reflecting a need
for basal rather than evoked ROK-mediated MLCP inhibition.
Cerebral vessel segments allowed to constrict in response
to increased intravascular pressure prior to treatment with
serotonin responded by increased constriction and demonstrated
a different pattern of MYPT1 phosphorylation. Serotonin
constriction evoked an increase in T855 phosphorylation that
was dependent on ROK activity (El-Yazbi et al., 2010). Prior
studies demonstrated an interplay between pressure- and
agonist-induced constriction whereby increased intraluminal
pressure increases the vessel sensitivity to agonist-induced
constriction (Harder, 1988; Lombard et al., 1990; VanBavel
and Mulvany, 1994). These results provided the first direct
evidence that this increased sensitivity occurs due to the
recruitment of ROK-mediated MYPT1 phosphorylation. In a
physiological milieu where the microvasculature is exposed
to pressure, it is likely that increased ROK activity is the
mechanism underlying the agonist mediated modulation of
vascular tone. The recruitment of this pathway in response
to other neurotransmitter and humoral mediators remains to
be confirmed in other vascular beds and with other agonists.
It remains very likely as demonstrated recently for P2Y6-
mediated purinergic constriction in mouse mesenteric arterioles
(Kauffenstein et al., 2016). Given the known modulation of
the arteriolar myogenic response by tissue metabolic demands
(Davis, 2012), it could be plausible that other physiological
parameters such as temperature, tissue oxygenation level, and
pH would affect ROK activity and impose an additional layer
of interplay. A potential molecular link would be similar to that
observed in cold-induced vasospasm whereby an enhanced ROK
activity was triggered by increased mitochondrial production
of reactive oxygen species culminating in vasoconstriction in
response to cold temperatures (Bailey et al., 2005). Indeed, a role
was suggested for reactive oxygen species in modulating calcium
sensitization during the myogenic constriction in response to
endogenous physiological/pathological stimuli (Nowicki et al.,
2001; Veerareddy et al., 2004; Keller et al., 2006; Gebremedhin
et al., 2014).
Further experimentation with combined agonist- and
pressure-evoked constriction revealed situations where cerebral
or skeletal muscle arterioles produced profound constrictions
with no recorded increased in LC20 phosphorylation level
(Moreno-Domínguez et al., 2013, 2014). With no detected
increases in the phosphorylation of caldesmon and calponin, the
proteins involved in thin-filament regulation, the contribution
of dynamic actin cytoskeleton re-organization was examined.
In addition to early studies mentioned before, the role of actin
polymerization was further emphasized by observations that
agents blocking actin polymerization interfered with myogenic
tone generation while those increasing F-actin formation
increased myogenic constriction (Cipolla et al., 2002). Yet
interpretation of these results begged the question of whether
myogenic contractility required an intact actin cytoskeletal
framework that is well-formed basally vs. a situation where
de novo actin polymerization occurs in response to increased
intravascular pressure. Similar to previous results (Cipolla et al.,
2002), a reduction in G-actin (unpolymerized) during generation
of myogenic contractility was evident, this reduction was
blocked with latrunculin B in rat cerebral and skeletal arterioles
(Moreno-Domínguez et al., 2013, 2014). Extending the range of
analysis further to higher pressure values, no further increase
in LC20 phosphorylation was observed beyond 80–100 mm
Hg, however, further constriction could be recorded in the face
of higher pressures. Under these experimental conditions, the
only biochemical parameter changing was a reduction in the
G-actin pool indicating actin cytoskeleton reorganization as the
sole force generation mechanism (Moreno-Domínguez et al.,
2014). Analysis of the circumferential wall stress of cerebral
arteriolar segments under these conditions estimated that actin
polymerization accounted for∼30% of the generated force. Both
the pressure-evoked constriction and G-actin pool reduction
under these conditions were sensitive to ROK inhibition. ROK
appears to cause an indirect increase in the phosphorylation
of cofilin through the activation of LIM kinase (Bernard,
2007). Phosphorylation suppresses cofilin ability to cap and
sever actin filaments (Carlier et al., 1997; Bernard, 2007).
Cofilin phosphorylation was increased with pressure-evoked
constriction and G-actin reduction, an observation that was
reversed in presence of a ROK inhibitor (Moreno-Domínguez
et al., 2014).
Taken together, these findings provide a direct biomolecular
context for the role of ROK in generation of myogenic
constriction. A basal component of ROK activity appears
to be required for force generation followed by a pressure-
evoked increase. ROK mediates force generation in the face
of increased intravascular pressure through facilitation of a
spectrum of mechanisms. Initially, the maintenance of a
background inhibition of MLCP allows a calcium-triggered
increase in LC20 phosphorylation. A graded increase in force
generation in the face of pressure is achieved by increased MYPT1
phosphorylation leading to increased LC20 phosphorylation in
an intracellular environment with no appreciable increases in
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calcium. Meanwhile, basal ROK activity is required for the
preservation of the integrity actin cytoskeleton allowing for
force transmission and contraction. Yet, dynamic ROK-mediated
actin reorganization appears to contribute to force generation
and eventually becomes the only mechanism underlying force
production after LC20 phosphorylation reaches its maximum
levels.
MECHANOTRANSDUCTION TO ROK
Mechanosensing mechanisms involving the contribution of ion
channels offer a straightforward model for linking pressure
sensation to arterial constriction that is dependent on calcium-
mediated MLCK activation and LC20 phosphorylation. However,
models involving membrane depolarization do not provide an
explanation for ROK activation. Previous reports in other cell
types linked mechanical activation of integrins to increased ROK
activity together with actin cytoskeleton remodeling (DeMali
et al., 2003; Legate et al., 2009). Blocking integrin function using
a function blocking antibody against α5 integrin or a peptide
that selectively blocks the function of α5 integrin reversed the
constriction obtained by increased intraluminal pressure and
reduced MYPT1 T855 and LC20 phosphorylation confirming
integrin signaling to ROK and MLCK/MLCP equilibrium in
general (Colinas et al., 2015; Mufti et al., 2015). Moreover,
vasodilation following antibody treatment was associated with
actin depolymerization and increased G-actin pool, again
establishing a clear connection between integrin activation and
actin polymerization (Colinas et al., 2015).
Upon examination of the phosphorylation status of focal
adhesion proteins in vessel segments producing myogenic
constriction, increased phosphorylation of both focal adhesion
kinase (FAK) at Y397 and Src family kinase (SFK) at Y416 was
identified as an early and essential event for the development
of myogenic constriction (Colinas et al., 2015). A pressure-
dependent increase in FAK phosphorylation at Y576/577 was
seen indicating a graded activity in response to pressure.
Treatment with inhibitors of these kinases abolished the
myogenic contractility and reduced MYPT1 and LC20
phosphorylation and actin cytoskeleton polymerization
indicating that FAK and SFK are activated down stream of
integrins in a pressure-dependent manner and relay signals
to pathways leading to calcium sensitization and actin
cytoskeleton polymerization involving ROK activity. FAK
and SFK phosphorylation and activation are proposed to mediate
this effect via stimulation of RhoGEFs (Momotani et al., 2011;
Lessey et al., 2012; Artamonov et al., 2013). A potential pathway
is outlined in Figure 1.
Several issues remain to be clarified by future research.
The calcium dependence of the integrin-mediated FAK and
SFK signaling needs to be examined. This might explain the
obligate dependence of the myogenic response on calcium despite
the demonstrated involvement of ROK-mediated calcium-
independent pathways. In addition, several observations indicate
that different force generation mechanisms are not necessarily
simultaneously activated at all pressure ranges, though all appear
to involve ROK activity. Whether this effect is due to a limited
effective range, e.g., LC20 phosphorylation reaching a maximum
level, or selective activation by disparate mechanotransduction
pathways remains to be determined. As well, GPCRs remain a
viable alternative pathway for mechanotransduction to ROK in
need for validation with direct molecular evidence in the context
of myogenic constriction.
ALTERATIONS IN ROK ACTIVITY IN
PATHOLOGICAL CONDITIONS
Given the crucial physiological role of the myogenic response in
cardiovascular homeostasis, it is predictable that dysfunctional
myogenic regulation of arterial diameter will be associated
with multiple vascular pathologies. Specifically, enhanced basal
myogenic tone may preclude the vasodilatory response of
resistance arteries in periods of high metabolic activity and
oxygen demand. The reduced arterial diameter would be
expected to restrict blood flow to the organ increasing the
risk of ischemia. These microvascular changes could provide
the starting point for further more permanent alterations in
the micro/macro-vasculature (Jax, 2010). Abnormal myogenic
constriction was observed in few pathological conditions such
as hypertension, hemorrhagic and ischemic stroke, diabetes, and
Alzheimer’s disease (Dunn et al., 1998; Smeda and King, 2000;
Coulson et al., 2002; Niwa et al., 2002; Izzard et al., 2003). With
ROK activity being an essential tenet of the myogenic response,
it becomes an attractive target for study and for potential
therapeutic interventions. Although the main focus of the next
section is type 2 diabetes, we speculate that aberrations in ROK
signaling leading to abnormal myogenic response in other disease
conditions will be comparable to what is reported in diabetes.
Both enhanced and reduced myogenic constriction has been
described in various animal models and patients of type 2 diabetes
(Lagaud et al., 2001; Schofield et al., 2002; Jarajapu et al., 2008;
Kold-Petersen et al., 2012; Sauve et al., 2016). One potential
cause for the apparent discrepancy in observations could be
studying vascular function at different disease stages even within
the same model. Goto-Kakizaki (GK) rat is a lean, polygenic
origin, spontaneous onset model of type 2 diabetes that offers
an exclusive opportunity to study diabetes-related characteristics
without the confounding influence of hyperlipidemia or obesity
(Nie et al., 2011). These rats demonstrate a phenotype of
insulin resistance prior to the development of type 2 diabetes
(Gao et al., 2010). Although reduced myogenic constriction was
reported in GK rats (Kold-Petersen et al., 2012), longitudinal
studies in cerebral arterioles of this model provided the
molecular basis for the progressive loss of myogenic response
from the prediabetic to the diabetic stage. Cerebral arterioles
from these rats demonstrated an enhanced myogenic behavior
during the prediabetic phase (Abd-Elrahman et al., 2015a).
Specifically, enhanced LC20 phosphorylation and increased actin
polymerization (lower G-actin level) occurred at low intraluminal
pressure due to an increase in ROK activity rather than ROK
protein expression. Significantly, a loss of the pressure-dependent
activation of myogenic response in prediabetic GK rats could
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FIGURE 2 | Proposed model for dysfunctional myogenic response in prediabetic GK rats. Two major defects were characterized in prediabetic GK cerebral
arteries: (A) Augmented ROK activity at low intraluminal pressure causing: (i) higher MYPT1-T855 phosphorylation, more inhibition of MLCP and higher myosin
phosphorylation; (ii) enhanced actin polymerization. (B) Abnormal FAK-Y397 phosphorylation downstream of integrin activation leading to loss of
pressure-dependent regulation of myogenic response. Supporting literature is cited on the figure.
be attributed to the observed loss of pressure-dependence of
FAK-Y397 phosphorylation downstream of integrin signaling.
These defects in mechanotransduction might lead to an abnormal
association between pressure and RhoA/ROK activation and,
thus, contribute to the loss of pressure-evoked change in LC20
and G-actin contents. The proposed model of the myogenic
abnormality seen in GK rats is depicted in Figure 2. Enhanced
ROK activity rather than its level of expression was a common
defect that has been characterized in most of the vascular beds
of prediabetic and diabetic animal models exhibiting augmented
contractile responses to agonists (Didion et al., 2005, 2006;
Matsumoto et al., 2010, 2014; Rao et al., 2013). The mechanism(s)
responsible for enhanced ROK activity in vascular smooth
muscle cells (VSMC) of type 2 diabetic animal models has not
been clearly characterized; however, a few candidates have been
suggested including: (i) increased oxidative stress that stimulates
the kinase activity; (ii) loss of endothelium-derived NO that
normally functions to suppress ROK activity (Loirand, 2006);
and/or (iii) selective impairment of insulin- and insulin receptor-
mediated signaling that suppresses RhoA activation and ROK
activity in VSMCs (Begum et al., 2001; Lee et al., 2008).
These observations make a case for targeting ROK as
a potential therapeutic intervention for vascular disorders
associated with diabetes. Indeed, Fasudil, a ROK inhibitor,
is approved in Japan for the treatment of vasospasm after
subarachnoid hemorrhage and also clinically effective for the
treatment of pulmonary hypertension (Shi and Wei, 2013).
Multiple limited clinical trials report a beneficial effect for ROK
inhibitors in systemic hypertension, vasospastic angina, stable
angina, ischemic stroke, and right ventricular failure (Shimizu
and Liao, 2016). However, given the crucial importance of
ROK in general vascular function, the utility and safety of such
pharmacological interventions in treatment of the widespread
vascular complications associated with diseases such as diabetes
will require substantial additional investigation. Examination
of the myogenic reactivity and the involvement of enhanced
ROK activity in other animal models of type 2 diabetes is
necessary. The high fat/high fructose fed rat provides a well-
characterized model for this purpose with a slow conversion from
prediabetes to diabetes (Lozano et al., 2016) and an adequately
reported profile of changes in adipose inflammatory mediators
(Sousa-Pinto et al., 2016). Moreover, emerging clinical evidence
paints a picture whereby newer oral hypoglycemic medications
might afford a direct effect on cardiovascular function leading
to reduced cardiovascular risk (Zinman et al., 2015; Marso
et al., 2016). Establishing whether these molecules affect vascular
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function, particularly myogenic contractility, and whether they
can modify ROK activity and/or expression could offer valuable
insight into the timing and pattern of use of these medications.
In conclusion, three major mechanisms have been well
characterized to underlie myogenic constriction including (i)
Ca2+-dependent activation of MLCK; (ii) ROK-dependent
inhibition of MLCP; and (iii) ROK dependent dynamic
actin cytoskeleton reorganization. It is now evident that the
relative contribution of the three mechanisms during myogenic
constriction is contingent on the intravascular pressure sensed
by the mechanosensors in the vascular wall, yet all three share
an obligate reliance on ROK activity. Moreover, the observed
dysfunctional myogenic response in a type 2 diabetic rat model
appeared to reflect an altered ROK activity. Delineating these
alterations in type 2 diabetes and other vascular disorders will
lead the search for new targets that could be clinically exploited in
the future to alleviate the progression of cardiovascular diseases.
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